ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Veterinary and Zoonotic Infection
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1591145
This article is part of the Research TopicSequencing Technologies in Advancing Veterinary and Zoonotic Infection ResearchView all 5 articles
A Multiplex Targeted NGS Panel for Identifying Pathogens in Canine Neurological and Reproductive Diseases
Provisionally accepted- 1Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- 2Animal Disease Diagnostic Laboratory, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States
- 3Pennsylvania Animal Diagnostic Laboratory System, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kenneth Square, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Multiple pathogens can infect the canine reproductive and central nervous systems, including organisms that are zoonotic, such as Brucella canis, pathogenic Leptospira spp., Anaplasma phagocytophilum, Histoplasma capsulatum, and Blastomyces dermatitidis. In this study, we developed a targeted next-generation sequencing (tNGS) panel to identify common infectious agents related to neurologic and reproductive disease in canines while incorporating less common zoonotic agents into a single test.Primer pools were developed to detect 34 pathogens and used in two multiplex PCR assays, which were combined prior to library preparation and sequencing using Ion Torrent technology. A feasibility study was performed with known positive clinical samples, bacterial isolates, or synthetic DNA (gBlocks) spiked into nucleic acids from negative canine clinical samples. Of the 34 organisms included in the panel, 33 were detectable. Analytical specificity was determined through in-silico evaluation of the primer sets as well as feasibility testing. Some primer sets were not specific for the intended target organism, based on BLAST analysis (NCBI) of the obtained sequences. Analytical sensitivity was evaluated with dilutions of gBlocks spiked into negative canine nucleic acid samples (for 10 organisms) or via testing dilutions of positive clinical samples and compared to Ct values from real-time PCR assays (for 13 organisms). Compared to real-time PCR assays, pathogens could be detected at Ct values from 33-38, depending on the pathogen, and at approximately 100-1000 copies based on gBlock testing. Diagnostic sensitivity and specificity testing were performed based on comparisons to those results from bacterial culture and real-time PCR assays. A total of 76 samples (39 positive and 40 negative) were tested, representing neurological and reproductive samples. Diagnostic sensitivity and Formatted: Superscript specificity for the assay were calculated as 89% and 98%, respectively. The tNGS assay had the added benefit of strain-typing Canine distemper virus and Canine parvovirus-2 in the positive samples. For reproducibility, a blinded panel was tested by our laboratory and another laboratory using the same tNGS protocol where the assay had an agreement for 16 out of 18 samples with a Cohen's kappa value of 0.77, indicating high reproducibility.
Keywords: targeted NGS, Ion-Torrent, canine reproductive disease, canine neurological disease, Molecular diagnostics
Received: 10 Mar 2025; Accepted: 17 Jun 2025.
Copyright: © 2025 Kattoor, Anis, Elshafie and Wilkes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Rebecca P. Wilkes, Animal Disease Diagnostic Laboratory, College of Veterinary Medicine, Purdue University, West Lafayette, 47907-2065, Indiana, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.